Epilepsy
📧 Sign up to get email alerts when something new happens for Epilepsy.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2024-10-09FDA Approved: LACOSAMIDE — Original Application (Somerset Therapeutics, LLC)
FDA approved the original application for lacosamide by Somerset Therapeutics, LLC, approving a generic version of the anticonvulsant.
-
FDA approval · 2024-10-02FDA Approved: PHENYTOIN SODIUM — Supplemental Application (Acella Pharmaceuticals, LLC)
FDA approved a supplemental application for phenytoin sodium from Acella Pharmaceuticals, LLC, approving a supplemental generic product unde…
-
FDA approval · 2024-10-01FDA Approved: LAMOTRIGINE — Original Application (Alembic Pharmaceuticals Limited)
FDA approved a generic lamotrigine product from Alembic Pharmaceuticals Limited under an Original Application (ANDA211821).
-
FDA approval · 2024-09-27FDA Approved: PHENYTOIN — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for phenytoin (PHENYTOIN) by Rising Pharma Holdings, Inc. under an ANDA.
-
FDA approval · 2024-09-24FDA Approved: FELBAMATE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
The FDA approved a supplemental application for felbamate from Amneal Pharmaceuticals of New York LLC, expanding the existing approval.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2024-09-24FDA Approved: CLOBAZAM — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for CLOBAZAM (clobazam) from Ascend Laboratories, LLC.
-
FDA approval · 2024-09-16FDA Approved: LEVETIRACETAM — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for LEVETIRACETAM submitted by Amneal Pharmaceuticals LLC. The action confirms approval of the refer…
-
FDA approval · 2024-09-16FDA Approved: CLOBAZAM — Supplemental Application (Amneal Pharmaceuticals NY LLC)
FDA approved a supplemental application for CLOBAZAM (clobazam) from Amneal Pharmaceuticals NY LLC under the ANDA pathway.
-
FDA approval · 2024-09-12FDA Approved: VIGABATRIN — Supplemental Application (Novadoz Pharmaceuticals LLC)
FDA approved a supplemental application for Vigabatrin by Novadoz Pharmaceuticals LLC. This action represents regulatory approval of an upda…
-
FDA approval · 2024-09-12FDA Approved: VIGABATRIN — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for Vigabatrin by Ascend Laboratories, LLC. The approval updates the regulatory status for Vigabatri…
-
FDA approval · 2024-09-12FDA Approved: VIGABATRIN — Supplemental Application (Carnegie Pharmaceuticals LLC)
FDA approved a supplemental application for Vigabatrin filed by Carnegie Pharmaceuticals LLC.
-
FDA approval · 2024-09-12FDA Approved: VIGABATRIN — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application to add Aurobindo Pharma Limited as an approved manufacturer of Vigabatrin.
-
FDA approval · 2024-09-12FDA Approved: SABRIL — Supplemental Application (Lundbeck Pharmaceuticals LLC)
FDA approved a supplemental application for Sabril (vigabatrin) submitted by Lundbeck Pharmaceuticals LLC. The approval updates the product …
-
FDA approval · 2024-09-12FDA Approved: VIGABATRIN — Supplemental Application (Dr. Reddys Laboratories Inc.,)
FDA approved a supplemental application for Vigabatrin from Dr. Reddy's Laboratories Inc. (ANDA 211481).
-
FDA approval · 2024-09-12FDA Approved: VIGABATRIN — Supplemental Application (Amneal Pharmaceuticals NY LLC)
The FDA approved a supplemental application for Vigabatrin from Amneal Pharmaceuticals NY LLC to market a generic Vigabatrin product.
-
FDA approval · 2024-09-12FDA Approved: VIGABATRIN — Supplemental Application (Actavis Pharma, Inc.)
FDA approved Actavis Pharma, Inc.'s supplemental application for Vigabatrin (ANDA 209822).
-
FDA approval · 2024-09-12FDA Approved: VIGADRONE — Supplemental Application (Upsher-Smith Laboratories, LLC)
The FDA approved a supplemental application for VIGADRONE (vigabatrin) by Upsher-Smith Laboratories, LLC under ANDA 210196.
-
FDA approval · 2024-09-12FDA Approved: VIGABATRIN — Supplemental Application (Cipla USA, Inc.)
FDA approves a supplemental application for vigabatrin submitted by Cipla USA, Inc. The approval updates the drug's labeling and/or indicati…
-
FDA approval · 2024-09-12FDA Approved: VIGABATRIN — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Vigabatrin from Aurobindo Pharma Limited under an ANDA, granting approval for a generic form of …
-
FDA approval · 2024-09-12FDA Approved: VIGADRONE — Supplemental Application (Upsher-Smith Laboratories, LLC)
The FDA approved a supplemental application for Vigadrone (vigabatrin) from Upsher-Smith Laboratories, confirming an approved supplement to …
-
FDA approval · 2024-09-10FDA Approved: TOPIRAMATE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for Topiramate from Zydus Lifesciences Limited, granting approval for a generic version of the anti-…
-
FDA approval · 2024-09-09FDA Approved: GABAPENTIN — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for gabapentin from Rising Pharma Holdings, Inc. The approval indicates a modification to the dr…
-
FDA approval · 2024-09-04FDA Approved: LACOSAMIDE — Original Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approves Unichem Pharmaceuticals' original application for lacosamide, enabling a generic version of the seizure medication. The approva…
-
FDA approval · 2024-08-29FDA Approved: LEVETIRACETAM — Supplemental Application (Solco healthcare U.S., LLC)
The FDA approved a supplemental application for a generic levetiracetam formulation developed by Solco Healthcare U.S., LLC.
-
FDA approval · 2024-08-28FDA Approved: LEVETIRACETAM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for a generic levetiracetam product from Aurobindo Pharma Limited.